Page last updated: 2024-08-05 10:54:06

phenanthrenes

Any benzenoid aromatic compound that consists of a phenanthrene skeleton and its substituted derivatives thereof.

ChEBI ID: 25961

Members (25)

MemberDefinitionRole
(4R,4aS,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one(4R,4aS,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
1-(2-phenanthrenyl)ethanone1-(2-phenanthrenyl)ethanone
1-methylphenanthreneA member of the class of phenanthrenes that is phenanthrene substituted by a methyl group at position 1.1-methylphenanthrene
3-nitroperylene3-Nitroperylene
6 beta-hydroxynaltrexone6alpha-Naltrexol
7-benzylidenenaltrexone7-Benzylidenenaltrexone
7-hydroxymethyl-12-methylbenz(a)anthracene7-Hydroxymethyl-12-methylbenz[a]anthracene
7-nitrobenzanthracene7-Nitrobenz[a]anthracene
9,10-phenanthrenequinone9,10-phenanthroquinone
benz(j)aceanthryleneBenz[j]aceanthrylene
benz(l)aceanthryleneBenz[l]aceanthrylene
benzanthrone7-benzo[a]phenalenone
chrysene-1,4-dionechrysene-1,4-dione
dibenzo(a,e)fluorantheneDibenzo[a,e]fluoranthene
dibenzo(aj)anthraceneDibenz[a,j]anthracene
halofantrine3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthrenyl]-1-propanol
HircinolHircinol
methylnaltrexonemethylnaltrexone
nitrobenzanthrone3-Nitrobenzanthrone
norbuprenorphineNorbuprenorphine
noroxycodoneNoroxycodone
noroxymorphoneNoroxymorphone
osu 03012A member of the class of pyrazoles that is N-[4-(pyrazol-1-yl)phenyl]glycinamide in which the pyrazole ring is substituted at positions 3 and 5 by trifluoromethyl and phenanthrene-2-yl groups respectively.OSU-03012
phenanthreneA polycyclic aromatic hydrocarbon composed of three fused benzene rings which takes its name from the two terms 'phenyl' and 'anthracene.'phenanthrene
trk 820nalfurafine

Research

Studies (3,601)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990315 (8.75)18.7374
1990's503 (13.97)18.2507
2000's1,101 (30.57)29.6817
2010's1,384 (38.43)24.3611
2020's298 (8.28)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials171 (4.47%)5.53%
Reviews147 (3.84%)6.00%
Case Studies83 (2.17%)4.05%
Observational2 (0.05%)0.25%
Other3,423 (89.47%)84.16%